HIV-1 gp160 (315-329)

Known as: P18(IIIB), P18III(B), P18IIIB

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.

2001

2001

Analysis of the extracellular processing of HIV-1 gp160-derived peptides using monoclonal antibodies specific to H-2Dd molecule complexed with p18-I10 peptide.

Katarína Poláková, Gustáv Russ
Acta virologica
2001

The immunodominant peptide of human immunodeficiency virus 1 gp 160 for murine cytotoxic T cells of H-2d haplotype, has been… (More)

Is this relevant?

2000

2000

Analysis of the mechanism for extracellular processing in the presentation of human immunodeficiency virus-1 envelope protein-derived peptide to epitope-specific cytotoxic T lymphocytes.

Yohko Nakagawa, Toshiyuki Takeshita, Jay A Berzofsky, Hidemi Takahashi
Immunology
2000

An immunodominant epitope of human immunodeficiency virus-1 (HIV-1) gp160 recognized by Dd class I major histocompatibility… (More)

Is this relevant?

1999

1999

Recombinant vaccinia viruses expressing an immunodominant epitope of HIV-1 envelope protein within an influenza hemagglutinin cassette predominantly prime epitope-specific CD8+ CTL

Marin Chiba, Hideyuki Takahashi, +4 authors Kuniaki Nerome
Archives of Virology
1999

We constructed recombinant vaccinia viruses (RVV) expressing a 15-residue peptide (P18IIIB; RIQRGPGRAFVTIGK) of gp160 envelope… (More)

Is this relevant?

1998

1998

Pilot study of the immunologic effects of recombinant human growth hormone and recombinant insulin-like growth factor in HIV-infected patients.

B Y Nguyen, Mario Clerici, +8 authors Robert Yarchoan
AIDS
1998

OBJECTIVE To study the immunologic effects of recombinant human growth hormone (rhGH), recombinant human insulin-like growth… (More)

Is this relevant?